1360095-69-7Relevant academic research and scientific papers
PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
-
Paragraph 0214, (2013/08/28)
The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
-
Page/Page column 34; 35, (2012/03/10)
Disclosed are pyrrolopyrimidine compounds of formula (I) capable of inhibiting JAK kinase, wherein R1, R2 and m are defined as in the description. The pharmaceutical compositions containing said pyrrolopyrimidine compounds and uses of said pyrrolopyrimidine compounds in the treatment of disorders or diseases such as inflammatory diseases and cancers are also disclosed.
PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
-
Page/Page column 30, (2012/03/10)
The present invention provides pyrrolopyrimidine compounds and methods of use therefor. In particular, the invention provides certain pyrrolopyrimidine compounds having the activity of inhibiting JAK kinases. The invention also provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds and use of these compounds in the treatment of inflammatory diseases and cancer.
